Order byBest matchMost fresh

FDA, COVID-19 pandemic and vaccine

Digest more
FDA Panel Recommends Monovalent COVID Vaccine for Next Season
An FDA advisory committee unanimously recommended Thursday that the next COVID vaccine should be a monovalent one in the JN.1 lineage, although members disagreed slightly about which specific strain should be included.

Continue reading

Who can get updated COVID vaccines this fall? FDA will OK for high-risk groups, calls for new clinical trials
FDA offers new guidelines to shift COVID vaccine focus to high-risk groups
FDA panel recommends keeping COVID shots targeted to same strain as last year
Advisers to the Food and Drug Administration have recommended COVID-19 vaccine makers continue to target their shots to the so-called JN.1 coronavirus strain for the upcoming fall and winter seasons, ...

Continue reading

FDA limits access to COVID-19 vaccine to older adults and other high-risk groups – a public health expert explains the new rules
wtvr · 17h
FDA advisory committee meets on COVID-19 vaccine after putting new restrictions on approvals
FDA plans to limit COVID vaccine to only high-risk people. Who would still be eligible?
Public trust in vaccination has declined, potentially impacting other vital immunization programs.

Continue reading

FDA panel debates COVID vaccine recipe as questions swirl about fall shots
US FDA Advisers to Weigh Composition of COVID Vaccines for 2025-2026
With vaccine approval process set to change, FDA advisers leave wiggle room in annual Covid-19 shot recommendations
A group of experts who advise the US Food and Drug Administration on its vaccine decisions voted unanimously Thursday to make a broad recommendation about which lineage of the coronavirus should be included in this year’s Covid-19 vaccines,
Changes are happening around COVID-19 vaccines: Here's what to know
The FDA plans to limit access to certain high-risk groups and also told Pfizer and Moderna to update their warning labels about heart inflammation.
BioSpace1h
FDA Vaccine Advisors Agree on COVID-19 Vaccine as New Framework Looms as ‘Elephant in the Room’
The advisory committee meeting comes days after the FDA unveiled a new risk-based approval framework for COVID-19 vaccines.
Mass. residents say they're not worried by new COVID vaccine guidelines
New guidelines for COVID vaccine. Prior to the new guidelines, it was recommended that everyone who is 6 months and older get at least one vaccine per year, with those in higher-0
FDA sets new COVID booster guidelines for healthy adults under 65
The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.
Trump's FDA Has Axed COVID Boosters For Most People — And Medical Experts Are Deeply Worried
The vaccine eligibility change is a threat to the health of Americans, some experts say, adding that the FDA is not being forthcoming about its research.
Federal Officials May Limit Recommendations for Covid Vaccine
With new testing requirements, it’s not even clear whether new Covid or flu shots can be made available this fall.
MAHA Influencer Slams Trump Admin COVID Vaccine Update—'Really Unfortunate'
"Here is a prime example of just how influential Big Pharma still is," MAHA influencer Diana Atieh told Newsweek.
Feedback